Medicine and Dentistry
Biological Marker
6%
Brachytherapy
30%
Cancer
16%
Cancer Cell
5%
Cervical Cancer
100%
Cervix
9%
Chemoradiotherapy
21%
Diffusion MRI
7%
Diseases
20%
Drug Megadose
9%
Endometrium Carcinoma
7%
External Beam Radiotherapy
9%
Fluorodeoxyglucose
18%
Fluorodeoxyglucose F 18
19%
High-Dose-Rate Brachytherapy
12%
Intensity Modulated Radiation Therapy
20%
Intracavitary Brachytherapy
7%
Magnetic Resonance Imaging
15%
Malignant Neoplasm
15%
Metabolism
18%
Metastatic Carcinoma
7%
Neoplasm
57%
Ovarian Cancer
6%
Overall Survival
25%
Pelvis
21%
Polyethylene Terephthalate
15%
Positron Emission Tomography
34%
Positron Emission Tomography-Computed Tomography
14%
Progression Free Survival
10%
Radiation Oncology
5%
Radiation Therapy
50%
Radiosensitivity
5%
Recurrent Disease
15%
Squamous Cell Carcinoma
10%
Squamous Cell Carcinoma Antigen
6%
Standardized Uptake Value
7%
Treatment Response
5%
Uterine Cancer
11%
Uterine Cervix Carcinoma
14%
Vulva
6%
Wart Virus
5%
Keyphrases
18F-fluorodeoxyglucose (18F-FDG)
5%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
10%
Brachytherapy
25%
Cervical Cancer
99%
Cervical Cancer Patients
19%
Cervical Carcinoma
14%
Chemoradiation
14%
Chemoradiotherapy
6%
Chemotherapy
11%
Clinical Outcomes
7%
Complete Metabolic Response
7%
Concurrent Chemotherapy
6%
Confidence Interval
6%
Definitive Chemoradiation
7%
Definitive Radiation
6%
Definitive Radiotherapy
6%
Endometrial Cancer
9%
External Beam Radiotherapy
6%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
17%
Fluorodeoxyglucose Positron Emission Tomography/computed Tomography
6%
Gene Expression
9%
Gynecologic Malignancies
9%
HDR Brachytherapy
16%
High Dose
7%
High-risk Human Papillomavirus (HR-HPV)
6%
Improved Survival
6%
In Cancer
8%
Intensity-modulated Radiation Therapy
20%
Intracavitary Brachytherapy
7%
Invasive Cervical Cancer
5%
Local Control
13%
Locally Advanced Cervical Cancer
6%
Magnetic Resonance Imaging
9%
Metabolic Response
13%
Ovarian Cancer
6%
Overall Survival
24%
Pancreatic Cancer
7%
Pancreatic Ductal Adenocarcinoma
5%
Positron Emission Tomography
16%
Positron Emission Tomography-computed Tomography (PET-CT)
6%
Progression-free Survival
8%
Radiation Therapy
30%
Radiotherapy
15%
Squamous Cell Carcinoma Antigen
11%
Standardized Uptake Value
7%
Survival Outcomes
10%
Tumor
29%
Tumor Immunity
6%
Tumor Response
6%
Vulvar Squamous Cell Carcinoma
6%